June 5, 2008 — A case study concerning the Axiom Worldwide’s DRX9000, published in the 2008 issue of the European Musculoskeletal Review, was mentioned in an online newsletter from the Food and Drug Administration (FDA).
The FDA news item was headlined, “Axiom Case Study Yields Favorable Findings with Back Pain Device.”
It read, in part, “A study evaluating Axiom Worldwide’s DRX9000 true nonsurgical spinal decompression system has produced positive results. … The study chronicled a patient who underwent 22 treatments with the device over a seven-week period and reported significant pain relief at the end of the study.”
Source: Axiom WorldWide, www.axiomworldwide.com
Related Posts
Become a reputation manager in your chiropractic practice- Dee Cee Labs founder and chiropractor Harry Hester passes at age 91
- NYCC Board of Trustees meets, salutes accomplishments of BLUEprint strategic plan’s first year
- What you need to know about chiropractic neurology
- ‘Strength care’ for athletic performance and to gain strength — part II
